New Ways to Treat Barth Syndrome
Selective inhibitors of MLCL/CytC Peroxidase in Barth Syndrome
This project is looking for new ways to stop the harmful processes that cause Barth Syndrome, aiming to find better treatments for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-11127603 on NIH RePORTER |
What this research studies
Barth Syndrome is a serious genetic condition that affects the heart, muscles, and immune system, often leading to a reduced quality of life and early death. Unfortunately, recent drug trials for this condition have not shown much success, highlighting the need for new approaches. This research aims to understand the core problem in Barth Syndrome by focusing on how certain fats in the body interact with proteins in our cells. By understanding this process better, we hope to discover new targets for medications that could effectively treat the condition.
Who could benefit from this research
Good fit: Patients with Barth Syndrome, particularly those who have not benefited from current or previous experimental treatments, are the ultimate focus of this research.
Not a fit: Patients without Barth Syndrome would not directly benefit from this specific research.
Why it matters
Potential benefit: If successful, this work could lead to the development of new, effective medications for Barth Syndrome, improving the health and quality of life for those affected.
How similar studies have performed: Previous clinical trials for Barth Syndrome treatments have not shown beneficial effects, making this a novel approach to understanding the disease mechanism and developing new therapies.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Kagan, Valerian E — University of Pittsburgh at Pittsburgh
- Study coordinator: Kagan, Valerian E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.